N.N. Alexandrov National Cancer Centre of Belarus

Minsk District 223040

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms

Studies at this site

• An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol — Completed